American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma

Author:

Chun Stephen G.1,Rimner Andreas2,Amini Arya3,Chang Joe Y.1,Donington Jessica4,Edelman Martin J.5,Geng Yimin1,Gubens Matthew A.6,Higgins Kristin A.7,Iyengar Puneeth8,Movsas Benjamin9,Ning Matthew S.1,Park Henry S.10,Rodrigues George11,Wolf Andrea12,Simone Charles B.13

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston

2. Memorial Sloan Kettering Cancer Center, New York, New York

3. City of Hope National Medical Center, Duarte, California

4. University of Chicago, Chicago, Illinois

5. Fox Chase Comprehensive Cancer Center, Philadelphia, Pennsylvania

6. Helen Diller Family Comprehensive Cancer Center, University of California San Francisco

7. Winship Cancer Institute, Emory University, Atlanta, Georgia

8. The University of Texas at Southwestern Medical Center, Dallas

9. Henry Ford Cancer Institute, Detroit, Michigan

10. Yale School of Medicine, New Haven, Connecticut

11. Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada

12. Mount Sinai Health System, New York, New York

13. New York Proton Center, New York, New York

Abstract

ImportanceThymic carcinoma is rare, and its oncologic management is controversial due to a paucity of prospective data. For this reason, multidisciplinary consensus guidelines are crucial to guide oncologic management.ObjectiveTo develop expert multidisciplinary consensus guidelines on the management of common presentations of thymic carcinoma.Evidence ReviewCase variants spanning the spectrum of stage I to IV thymic carcinoma were developed by the 15-member multidisciplinary American Radium Society (ARS) Thoracic Appropriate Use Criteria (AUC) expert panel to address management controversies. A comprehensive review of the English-language medical literature from 1980 to 2021 was performed to inform consensus guidelines. Variants and procedures were evaluated by the panel using modified Delphi methodology. Agreement/consensus was defined as less than or equal to 3 rating points from median. Consensus recommendations were then approved by the ARS Executive Committee and subject to public comment per established ARS procedures.FindingsThe ARS Thoracic AUC panel identified 89 relevant references and obtained consensus for all procedures evaluated for thymic carcinoma. Minimally invasive thymectomy was rated as usually inappropriate (regardless of stage) due to the infiltrative nature of thymic carcinomas. There was consensus that conventionally fractionated radiation (1.8-2 Gy daily) to a dose of 45 to 60 Gy adjuvantly and 60 to 66 Gy in the definitive setting is appropriate and that elective nodal irradiation is inappropriate. For radiation technique, the panel recommended use of intensity-modulated radiation therapy or proton therapy (rather than 3-dimensional conformal radiotherapy) to reduce radiation exposure to the heart and lungs.Conclusions and RelevanceThe ARS Thoracic AUC panel has developed multidisciplinary consensus guidelines for various presentations of thymic carcinoma, perhaps the most well referenced on the topic.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3